Standard BioTools Inc (LAB)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Research and Development Expense (Quarterly): 15.98M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.98M |
| December 31, 2023 | 6.909M |
| September 30, 2023 | 6.37M |
| June 30, 2023 | 6.184M |
| March 31, 2023 | 6.429M |
| December 31, 2022 | 7.425M |
| September 30, 2022 | 8.486M |
| June 30, 2022 | 12.61M |
| March 31, 2022 | 8.865M |
| December 31, 2021 | 8.541M |
| September 30, 2021 | 9.209M |
| June 30, 2021 | 9.441M |
| March 31, 2021 | 10.75M |
| December 31, 2020 | 11.19M |
| September 30, 2020 | 8.128M |
| June 30, 2020 | 8.448M |
| March 31, 2020 | 8.699M |
| December 31, 2019 | 8.278M |
| September 30, 2019 | 7.125M |
| June 30, 2019 | 7.865M |
| March 31, 2019 | 8.372M |
| December 31, 2018 | 7.958M |
| September 30, 2018 | 7.43M |
| June 30, 2018 | 7.386M |
| March 31, 2018 | 7.256M |
| Date | Value |
|---|---|
| December 31, 2017 | 7.158M |
| September 30, 2017 | 7.683M |
| June 30, 2017 | 7.461M |
| March 31, 2017 | 8.524M |
| December 31, 2016 | 8.773M |
| September 30, 2016 | 9.252M |
| June 30, 2016 | 9.978M |
| March 31, 2016 | 10.41M |
| December 31, 2015 | 9.74M |
| September 30, 2015 | 9.444M |
| June 30, 2015 | 10.09M |
| March 31, 2015 | 9.99M |
| December 31, 2014 | 11.72M |
| September 30, 2014 | 12.69M |
| June 30, 2014 | 11.37M |
| March 31, 2014 | 7.646M |
| December 31, 2013 | 5.755M |
| September 30, 2013 | 5.004M |
| June 30, 2013 | 4.997M |
| March 31, 2013 | 4.197M |
| December 31, 2012 | 4.265M |
| September 30, 2012 | 4.071M |
| June 30, 2012 | 3.987M |
| March 31, 2012 | 4.279M |
| December 31, 2011 | 4.001M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
6.184M
Minimum
Jun 2023
15.98M
Maximum
Mar 2024
8.846M
Average
8.467M
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp | 81.80M |
| Azenta Inc | 8.707M |
| Harvard Bioscience Inc | 2.885M |
| Bionano Genomics Inc | 9.779M |
| Akoya Biosciences Inc | 5.554M |